InvestorsObserver
×
News Home

Should You Accumulate Berkeley Lights Inc (BLI) in Biotechnology Industry?

Monday, March 06, 2023 03:06 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Accumulate Berkeley Lights Inc (BLI) in Biotechnology Industry?

The 40 rating InvestorsObserver gives to Berkeley Lights Inc (BLI) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 35 percent of stocks in the Biotechnology industry, BLI’s 40 overall rating means the stock scores better than 40 percent of all stocks.

Overall Score - 40
BLI has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on BLI!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 40 would rank higher than 40 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Berkeley Lights Inc Stock Today?

Berkeley Lights Inc (BLI) stock is down -9.78% while the S&P 500 is up 0.16% as of 3:06 PM on Monday, Mar 6. BLI has fallen -$0.18 from the previous closing price of $1.84 on volume of 381,953 shares. Over the past year the S&P 500 is down -3.55% while BLI has fallen -71.96%. BLI lost -$1.42 per share the over the last 12 months. Click Here to get the full Stock Report for Berkeley Lights Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App